4.7 Review

Reduction in colorectal cancer incidence by screening endoscopy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Cost-Effectiveness of Earlier or More Intensive Colorectal Cancer Screening in Overweight and Obese Patients

Aaron Yeoh et al.

Summary: Cost-effectiveness analysis showed that starting colorectal cancer (CRC) screening at 45 years of age with colonoscopy or at 40 years of age with FIT (fecal immunochemical test) is cost-effective for both women and men with different body mass index (BMI). In men with obesity II-III, colonoscopy starting at 40 years of age was found to be more cost-effective.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Medicine, General & Internal

Prevalence of Colorectal Neoplasia 10 or More Years After a Negative Screening Colonoscopy in 120 000 Repeated Screening Colonoscopies

Thomas Heisser et al.

Summary: A study in Germany found that the prevalence of cancer or adenomas at least 10 years after a negative colonoscopy result was low. The extension of the currently recommended 10-year screening intervals may be necessary, especially for female and younger participants without gastrointestinal symptoms.

JAMA INTERNAL MEDICINE (2023)

Article Oncology

Colorectal cancer statistics, 2023

Rebecca L. Siegel et al.

Summary: Colorectal cancer is the second leading cause of cancer death in the United States. The incidence of CRC has slowed down, but it is shifting to a younger age, advanced stage, and left colon/rectum. Mortality from CRC has declined overall, but increased in individuals younger than 50 years and Native Americans younger than 65 years. Uncovering the reasons for rising incidence and improving access to screening and treatment are crucial in combating CRC.

CA-A CANCER JOURNAL FOR CLINICIANS (2023)

Article Gastroenterology & Hepatology

Risk-Stratified Screening for Colorectal Cancer Using Genetic and Environmental Risk Factors: A Cost-Effectiveness Analysis Based on Real-World Data

Rosita van den Puttelaar et al.

Clinical Gastroenterology and Hepatology (2023)

Article Gastroenterology & Hepatology

Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN

Eileen Morgan et al.

Summary: Colorectal cancer is the third most common cancer worldwide, with the highest incidence rates in Australia/New Zealand and Europe, and the lowest rates in Africa and Southern Asia. The burden of colorectal cancer is projected to increase by 2040, with the majority of cases predicted to occur in high HDI countries.
Letter Gastroenterology & Hepatology

Significant underestimation of preventive effects in colorectal cancer screening trial

Thomas Heisser et al.

Review Oncology

Early-Onset Cancer in the Gastrointestinal Tract Is on the Rise-Evidence and Implications

Irit Ben-Aharon et al.

Summary: Data shows a significant increase in the incidence of colorectal cancer in younger populations, as well as similar trends in gastric, pancreatic, and biliary tract cancers. The majority of these cases are sporadic and not hereditary, suggesting a potential role for behavioral, lifestyle, nutritional, microbial, and environmental factors. This review explores the current understanding and challenges of early-onset gastrointestinal cancer, and emphasizes the need for further research to develop preventive strategies and tailored early detection.

CANCER DISCOVERY (2023)

Review Gastroenterology & Hepatology

Emerging Tests for Noninvasive Colorectal Cancer Screening

Marina Hanna et al.

Summary: Colorectal cancer is a common cancer globally and is a leading cause of cancer-related deaths. Current screening methods for colorectal cancer have limitations and many people are not compliant with screening recommendations. Novel screening tests based on advances in molecular biology, genetics, and epigenetics, as well as sequencing technologies and computational analytic methods, have been developed to improve early detection of colorectal cancer.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Medicine, General & Internal

Long-Term Follow-up of the Italian Flexible Sigmoidoscopy Screening Trial

Carlo Senore et al.

Summary: The study demonstrates that a single FS screening has a long-term protective effect on both CRC incidence and mortality, lasting up to 15 and 19 years. There was a significant reduction in colorectal cancer mortality among men, while no significant effect was observed among women.

ANNALS OF INTERNAL MEDICINE (2022)

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Oncology

Trends in the incidence of early-onset colorectal cancer in all 50 United States from 2001 through 2017

Rajesh R. Shah et al.

Summary: The incidence of colorectal cancer among US adults aged 20 to 49 years increased from 2001 to 2017, with the fastest increases observed from 2012 to 2017. Increases were observed among the youngest age groups, among non-Hispanic Whites, and in states in the West, Midwest, and Rocky Mountain regions. Increasing rates across all tumor stages suggest a real increase in CRC incidence.

CANCER (2022)

Review Gastroenterology & Hepatology

Current and future colorectal cancer screening strategies

Aasma Shaukat et al.

Summary: This Review provides an overview of current CRC screening options worldwide, including colonoscopy and stool-based tests. It also highlights the key features of each modality and describes new screening tests under development.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)

Review Medicine, General & Internal

Increasing Incidence of Early-Onset Colorectal Cancer

Frank A. Sinicrope

Summary: Early-onset colorectal cancer, which accounts for 10% of cases, is increasing in incidence, particularly in high-income countries. Patients often present with advanced disease in the left colon, and one in six patients has deficient DNA mismatch repair. Screening is recommended to begin at 45 years of age.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Gastroenterology & Hepatology

Proportion and stage distribution of screen-detected and non-screen-detected colorectal cancer in nine European countries: an international, population-based study

Rafael Cardoso et al.

Summary: This study analyzed the potential effects of colorectal cancer screening programs in several European countries. The results showed that the proportion of screen-detected colorectal cancers varied widely between countries. Screen-detected cancers were more likely to be detected at an early stage compared to non-screen-detected cancers.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2022)

Review Gastroenterology & Hepatology

The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection

Swati G. Patel et al.

Summary: This Series paper provides a comprehensive review on the topic of early-onset colorectal cancer, including examining the epidemiology, clinical and pathological features, genetic and epigenetic landscapes, and emerging data on clinical risk factors associated with this malignancy. Evidence-based approaches to prevention and early detection are also presented.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2022)

Article Medicine, General & Internal

Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death

M. Bretthauer et al.

Summary: This randomized trial found that participants who were invited to undergo screening colonoscopy had a lower risk of colorectal cancer within 10 years.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Oncology

Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests

Elisabeth F. P. Peterse et al.

Summary: The study found that among alternative screening methods, computed tomographic colonography every 5 years, annual mSEPT9, and annual multi-target stool DNA screening are the most cost-effective choices. However, these alternative tests are not cost-effective compared to FIT and colonoscopy.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Article Gastroenterology & Hepatology

Strong Reduction of Colorectal Cancer Incidence and Mortality After Screening Colonoscopy: Prospective Cohort Study From Germany

Feng Guo et al.

Summary: In this large prospective cohort study from Germany, screening colonoscopy was associated with a strong reduction in colorectal cancer (CRC) incidence and mortality.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

Article Oncology

Effects of screening for colorectal cancer: Development, documentation and validation of a multistate Markov model

Thomas Heisser et al.

Summary: Simulation models, such as the COSIMO model, are powerful tools for evaluating the effectiveness of colorectal cancer screening strategies. This specific model accurately predicted colorectal neoplasm prevalence and incidence in a German population for up to 25 years, showing potential for assessing comparative effectiveness of screening strategies.

INTERNATIONAL JOURNAL OF CANCER (2021)

Article Oncology

Model based evaluation of long-term efficacy of existing and alternative colorectal cancer screening offers: A case study for Germany

Thomas Heisser et al.

Summary: By comparing current and alternative CRC screening offers in a case study for Germany, it was found that three colonoscopies yield the highest reductions in lifetime risks of CRC and combining annual FIT screening and both colonoscopy modalities also had significant effects. Additional screening for elderly men after age 70 further reduced the risk of dying from CRC, while three colonoscopies outperformed current screening offers for women across all outcomes.

INTERNATIONAL JOURNAL OF CANCER (2021)

Review Medicine, General & Internal

Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

Jennifer S. Lin et al.

Summary: There are multiple screening options for colorectal cancer, each with varying levels of evidence in reducing cancer mortality, detecting cancer or precursor lesions, and risks of harms. This systematic review summarizes published evidence on the benefits and harms of screening for colorectal cancer in asymptomatic, community-dwelling adults to support the 2021 US Preventive Services Task Force Recommendation Statement.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Oncology

Screening for Colorectal Cancer in the United States: Correlates and Time Trends by Type of Test

Jean A. Shapiro et al.

Summary: In 2018, an estimated 66.9% of U.S. adults aged 50-75 had colorectal cancer screening, with colonoscopy, FOBT/FIT, and FIT-DNA being the most commonly used screening types within recommended intervals. Despite some progress, colorectal cancer testing remains low in certain population subgroups, indicating efforts are needed to reach screening goals.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)

Article Oncology

Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study

Rafael Cardoso et al.

Summary: There are diverse trends in colorectal cancer incidence, mortality, and stage distribution across European countries, mainly due to variations in the implementation of colorectal cancer screening programs.

LANCET ONCOLOGY (2021)

Article Gastroenterology & Hepatology

Perforation and post-polypectomy bleeding complicating colonoscopy in a population-based screening program

Lawrence F. Paszat et al.

Summary: Colonic perforation and post-polypectomy bleeding, as complications among participants of the ColonCancerCheck program in Ontario, Canada, who test positive in the absence of colorectal cancer, are rare but serious, with higher rates seen in older patients and those with comorbidities. The characteristics of the endoscopist also play a role in the occurrence of these complications.

ENDOSCOPY INTERNATIONAL OPEN (2021)

Review Gastroenterology & Hepatology

Strategies for Colorectal Cancer Screening

Uri Ladabaum et al.

GASTROENTEROLOGY (2020)

Article Oncology

Colorectal cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Editorial Material Endocrinology & Metabolism

The obesity transition: stages of the global epidemic

Lindsay M. Jaacks et al.

LANCET DIABETES & ENDOCRINOLOGY (2019)

Article Medicine, General & Internal

Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study

Maaike Buskermolen et al.

BMJ-BRITISH MEDICAL JOURNAL (2019)

Review Medicine, General & Internal

Outcomes at follow-up of negative colonoscopy in average risk population: systematic review and meta-analysis

Thomas Heisser et al.

BMJ-BRITISH MEDICAL JOURNAL (2019)

Review Gastroenterology & Hepatology

Cost-Effectiveness of Colorectal Cancer Screening Strategies-A Systematic Review

Tao Ran et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

Article Gastroenterology & Hepatology

Optimal age for screening colonoscopy: a modeling study

Chen Chen et al.

GASTROINTESTINAL ENDOSCOPY (2019)

Article Medicine, General & Internal

The IARC Perspective on Colorectal Cancer Screening

Beatrice Lauby-Secretan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Public, Environmental & Occupational Health

Diagnostic performance of flexible sigmoidoscopy combined with fecal immunochemical test in colorectal cancer screening: meta-analysis and modeling

Tobias Niedermaier et al.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2017)

Article Oncology

Colorectal cancer statistics, 2017

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2017)

Article Gastroenterology & Hepatology

Prevention, Early Detection, and Overdiagnosis of Colorectal Cancer Within 10 Years of Screening Colonoscopy in Germany

Hermann Brenner et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)

Article Medicine, General & Internal

Effect of Flexible Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality A Randomized Clinical Trial

Oyvind Holme et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)

Article Medicine, General & Internal

Multitarget Stool DNA Testing for Colorectal-Cancer Screening

Thomas F. Imperiale et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Medicine, General & Internal

Multitarget Stool DNA Testing for Colorectal-Cancer Screening

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Oncology

Natural History of Colorectal Adenomas: Birth Cohort Analysis Among 3.6 Million Participants of Screening Colonoscopy

Hermann Brenner et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)

Article Health Care Sciences & Services

In the era of widespread endoscopy use, randomized trials may,strongly underestimate the effects of colorectal cancer screening

Hermann Brenner et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)

Article Medicine, General & Internal

Long-Term Mortality after Screening for Colorectal Cancer

Aasma Shaukat et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Oncology

Patterns of Colorectal Cancer Test Use, Including CT Colonography, in the 2010 National Health Interview Survey

Jean A. Shapiro et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)

Article Public, Environmental & Occupational Health

Sojourn Time of Preclinical Colorectal Cancer by Sex and Age: Estimates From the German National Screening Colonoscopy Database

Hermann Brenner et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)

Review Gastroenterology & Hepatology

Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): An update

Paul Hewitson et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)